Evaluation of urinary cyclic 3'5'-adenosine monophosphate excretion in the differential diagnosis of hypercalcemia.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000150:complications; D002283:Carcinoma, Bronchogenic / Q000150:complications; D002740:Chlorothiazide; D000242:Cyclic AMP / Q000652:urine*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology / Q000652:urine*; D006961:Hyperparathyroidism / Q000097:blood / Q000150:complications / Q000652:urine; D006965:Hyperplasia / Q000150:complications; D007118:Immunoassay; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010281:Parathyroid Hormone / Q000032:analysis / Q000097:blood; D010282:Parathyroid Neoplasms / Q000150:complications; D014508:Urea / Q000097:blood
D010281:Parathyroid Hormone; D002740:Chlorothiazide; D014508:Urea; D000242:Cyclic AMP